-
Management Board: Highlights of March 2021 meeting
Management Board: Highlights of March 2021 meeting
-
Management Board: Highlights of March 2021 meeting
Management Board: Highlights of March 2021 meeting
The Board was updated on EMA’s activities in response to the pandemic, the Agency’s independence policies and progress with the clinical trial information system
-
PRAC highlights March 2021
PRAC highlights March 2021
-
PRAC highlights March 2021
PRAC highlights March 2021
Outcomes from the March meeting cover all aspects of the risk management of the use of medicines, including COVID-19 treatments and vaccines
-
Fourth COVID-19 vaccine authorised in the EU
Fourth COVID-19 vaccine authorised in the EU
-
Fourth COVID-19 vaccine authorised in the EU
Fourth COVID-19 vaccine authorised in the EU
The European Commission has granted a conditional marketing authorisation for COVID-19 Vaccine Janssen following EMA’s recommendation
-
Public meeting on COVID-19 vaccines: Friday 26 March
Public meeting on COVID-19 vaccines: Friday 26 March
-
Public meeting on COVID-19 vaccines: Friday 26 March
Public meeting on COVID-19 vaccines: Friday 26 March
Apply now to join the virtual room during our third public meeting, about the approval, safety monitoring and expected impact of COVID-19 vaccines or watch live on the day.
